Invesco Mortgage Capital Inc. (IVR) Stock Price & Analysis
Invesco Mortgage Capital Inc. (IVR) closed at USD 5.52 on Thursday, October 22, 2026, up 1.85% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 5.42; the Oct 22, 2026 session ranged USD 5.41–5.59 on volume of 3,645,270 shares. Market capitalization is $601.68M, with a 52-week range of USD 5.22–9.5 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 11:03 UTC.
Also available as compact Markdown for AI agents: nexqual.com/IVR.md
Key facts (IVR)
- Valuation: P/E 5.0x (avg 6.4x at the last 2 fiscal year-ends).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $14K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 3.17 on a 1–5 scale) (6 analysts), mean target USD 8.17 (range 7.25–9.5).
- Total return with dividends: 1Y -10.2% vs S&P 500 +14.9%; 5Y -57.1% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 0.46, revenue estimate $59.2M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (IVR)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Net income | -$90.0M | -$403M | -$15.9M | $59.9M | $101M | $120M |
| EPS (diluted) | -$4.82 | -$12.21 | -$0.85 | $0.65 | $1.32 | — |
| Cash + short-term investments | $357M | $176M | $77.0M | $73.4M | $56.0M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (IVR)
P/E 5.0x · P/B 0.6x · Earnings yield 19.95%
P/E at fiscal year-ends: Dec 2025 5.6x, Dec 2024 7.2x.
Insider purchases (SEC Form 4, open-market, last ~7 months) (IVR)
1 purchase, $14K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-05-05 | Gregson Mark William | Chief Financial Officer | 1,750 | $14K | 8.03 | Too little history (no open-market trades in 2023–2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (IVR)
Consensus Hold (mean 3.17 on a 1–5 scale), 6 analysts; mean target USD 8.17 (low 7.25, high 9.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-19 | UBS | Target lowered | Neutral | $8.25 → $7.75 |
Total return (dividends reinvested) (IVR)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -10.2% | -57.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -10.2% | -15.5% |
| Volatility (annualized) | 23.6% | 37.6% |
| Max drawdown | -36.0% (Jan 2026→Oct 2026) | -72.4% (Nov 2021→Oct 2023) |
IVR suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | IAS Operating Partnership | “We conduct our business through IAS Operating Partnership L.P. (the "Operating Partnership") and have one operating segment.” |
Quoted from the company's 10-K filed Feb 23, 2026.
IVR analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.46 | $0.52 | -11.9% | $59.2M | 6 |
| Next quarter (ends Dec 2026) | $0.44 | $0.51 | -13.0% | $58.0M | 6 |
| Current fiscal year (ends Dec 2026) | $1.93 | $2.06 | -6.2% | $225.7M | 6 |
| Next fiscal year (ends Dec 2027) | $1.66 | $2.02 | -17.6% | $243.9M | 6 |
IVR options: expected move
Options price a move of about ±11.8% (±$0.65) by Nov 20, 2026, which includes earnings on Oct 29, 2026. Over the last 8 reports the stock moved ±2.1% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 28.7% | ±11.8% |
| Dec 18, 2026 | 56 | 34.8% | ±15.3% |
| Jan 15, 2027 | 84 | 55.4% | ±24.9% |
| Apr 16, 2027 | 175 | 58.4% | ±35.8% |
30-day implied volatility 37.1% vs 29.5% realized over the last 30 trading days. Put/call ratio (volume) 0.17. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 11:03 UTC)
| Price | USD 5.52 |
|---|---|
| Change | ▲ 1.85% (up) |
| Previous Close | USD 5.42 |
| Open | USD 5.42 |
| Day Range | USD 5.41 – 5.59 |
| 52-Week Range | USD 5.22 – 9.5 |
| Volume | 3,645,270 shares |
| Market Cap | $601.68M |
| Exchange | NYQ |
Technical Analysis (IVR)
Nexqual's technical model rates IVR "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 11:03 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 31.71 (neutral) |
| vs SMA50 | Below (USD 6.53) |
| MACD | -0.32 (negative) |
Analyst Ratings (IVR)
Wall Street analysts rate IVR "Hold" based on 6 analysts, with a mean price target of USD 8.17 (range USD 7.25–9.5), per Nexqual as of October 23, 2026 at 11:03 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 8.17 |
| High Target | USD 9.5 |
| Low Target | USD 7.25 |
| Buy / Hold / Sell | 1 / 4 / 1 |
Earnings (IVR)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.46 |
| Revenue Estimate | $59.24M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.5 vs est 0.52 ▼ miss |
| 2026-03-31 | USD 0.55 vs est 0.55 ▼ miss |
| 2025-12-31 | USD 0.56 vs est 0.56 ▲ beat |
| 2025-09-30 | USD 0.58 vs est 0.58 ▲ beat |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
Financials & Fundamentals (IVR)
| Total Revenue | $139.44M |
|---|---|
| Gross Margin | +100.00% |
| Operating Margin | +86.52% |
| Profit Margin | +86.11% |
| ROE | +14.13% |
| Debt / Equity | 6.27 |
| Current Ratio | 0.05 |
| Total Cash | $89.89M |
| Total Debt | $6.21B |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
Financial Health Score (IVR)
Nexqual rates Invesco Mortgage Capital Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 11:03 UTC.
| Growth | Weak — Revenue -5% YoY (annual), declining |
|---|---|
| Profitability | Strong — Operating margin 87% |
| Balance Sheet | Critical — $90M cash vs $6.21B debt |
| Cash Flow | Solid — Operating cash flow $157M (FY ended Dec 2025, 10-K) |
| Efficiency | Mixed — ROE 14%, ROA 1.9% |
Ownership (IVR)
| Insider Ownership | +0.26% |
|---|---|
| Institutional Ownership | +44.62% |
| Shares Outstanding | 109.00M |
| Float | 107.36M |
| Short % of Float | +10.61% |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
Leadership (IVR)
Invesco Mortgage Capital Inc. is led by Kevin M. Collins, Chief Executive Officer, per Nexqual as of October 23, 2026 at 11:03 UTC.
| Chief Executive Officer | Kevin M. Collins |
|---|---|
| President | David B. Lyle |
| Chief Financial Officer | Mark William Gregson |
| Executive Director | Stephanie J. Larosiliere |
Major Backers & Investors (IVR)
Notable institutional backers of Invesco Mortgage Capital Inc. include Mirae Asset Global ETFs Holdings Ltd., Invesco, GLOBAL X FUNDS-Global X SuperDividend ETF, according to Nexqual as of October 23, 2026 at 11:03 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Mirae Asset Global ETFs Holdings Ltd. | 3.07% |
| Invesco | 2.25% |
| GLOBAL X FUNDS-Global X SuperDividend ETF | 2.19% |
| VanEck ETF Trust-VanEck Mortgage REIT Income ETF | 1.32% |
| Ascentis Wealth Management, LLC | 1.2% |
| Two Sigma Investments, LP | 1.2% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.18% |
| Vanguard Group | 3.71% |
| Geode Capital | 2.21% |
| State Street | 1.72% |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
From Invesco Mortgage Capital Inc.'s Latest SEC 10-K Filing (filed 2026-02-23)
Partnerships
- Our Manager maintains extensive long-term relationships with other financial intermediaries, including primary dealers, leading investment banks, brokerage firms, leading mortgage originators and commercial banks.
- Treasury securities to hedge all or a portion of the interest rate risk associated with the financing of our investment portfolio.
Legal & Regulatory Risks (Item 1A, quoted)
- The Federal conservatorship of Fannie Mae and Freddie Mac and related efforts, along with any changes in laws and regulations affecting the relationship between these agencies and the U.S. Government, may adversely affect our business.
- We may be subject to adverse legislative or regulatory tax changes that could increase our tax liability, reduce our operating flexibility and reduce the price of our stock.
- Compliance with REIT requirements may cause us to forgo otherwise attractive opportunities, which may hinder or delay our ability to meet our investment objectives and reduce your overall return.
- Compliance with REIT requirements may force us to liquidate or restructure otherwise attractive investments.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ABR | Arbor Realty Trust | USD 2.96 | ▲ 2.07% |
| MFA | MFA Financial, Inc. | USD 6.62 | ▲ 2.32% |
| ADAM | Adamas Trust, Inc. | USD 7.73 | ▲ 3.9% |
| FBRT | Franklin BSP Realty Trust, Inc. | USD 6.25 | ▲ 3.82% |
| CIM | Chimera Investment Corporation | USD 8.45 | ▲ 2.55% |
| TRTX | TPG RE Finance Trust, Inc. | USD 6.22 | ▲ 6.32% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 11:03 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt